Oxurion (Euronext Brussels: OXUR) is a Belgian company building a leading European group of contract research organisations through buy-and-build acquisitions. The company owns a 72% controlling stake in Axiodis CRO, a French specialist in clinical biometrics data management, and operates the proprietary Exagis CDMS platform. Oxurion operates across 12+ countries with partnerships spanning 20+ academic, biotech, and pharma entities.
Pascal Ghoson - Chief Executive Officer